Hypoglycemia begets hypoglycemia: The order effect in the ASPIRE in-clinic study

Diabetes Technology and Therapeutics

Volumn 16, Issue 3, 2014, Pages 125-130

  Garg, Satish K ^a   Brazg, Ronald L ^b   Bailey, Timothy S ^c   Buckingham, Bruce A ^d   Slover, Robert H ^a   Klonoff, David C ^e   Shin, John ^f   Welsh, John B ^f   Kaufman, Francine R ^f  

^a UNIVERSITY OF COLORADO   (United States)

^b Rainier Clinical Research Center   (United States)

^c AMCR Institute   (United States)

^d STANFORD UNIVERSITY   (United States)

^e Mills Peninsula Health Services   (United States)

^f MEDTRONIC INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; LACTIC ACID; ANTIDIABETIC AGENT; GLUCOSE BLOOD LEVEL; HEMOGLOBIN A1C PROTEIN, HUMAN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSSOVER PROCEDURE; EVALUATION STUDY; EXERCISE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPOGLYCEMIA; LACTATE BLOOD LEVEL; OBSERVATIONAL STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; ADULT; AMBULATORY MONITORING; AREA UNDER THE CURVE; DIABETES MELLITUS, TYPE 1; FEMALE; INSULIN INFUSION; MALE; METABOLISM; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ADULT; AREA UNDER CURVE; BLOOD GLUCOSE; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 1; EXERCISE; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MONITORING, AMBULATORY; TREATMENT OUTCOME;

EID: 84896900619     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2013.0219     Document Type: Article

References (16)

1. Cryer PE: Death during intensive glycemic therapy of diabetes: mechanisms and implications. Am J Med 2011;124: 993-996.
2. Cryer PE: Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes 2005;54:3592-3601.
3. Brazg RL, Bailey TS, Garg S, Buckingham BA, Slover RH, Klonoff DC, Nguyen X, Shin J, Welsh JB, Lee SW: The ASPIRE study: design and methods of an in-clinic crossover trial on the efficacy of automatic insulin pump suspension in exercise-induced hypoglycemia. J Diabetes Sci Technol 2011;5:1466-1471.
4. Garg S, Brazg RL, Bailey TS, Buckingham BA, Slover RH, Klonoff DC, Shin J, Welsh JB, Kaufman FR: Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study. Diabetes Technol Ther 2012;14:205-209.
5. Garg S, Brazg RL, Bailey TS, Buckingham BA, Klonoff DC, Shin J, Welsh JB, Kaufman FR: The order effect of the in-clinic ASPIRE study: hypoglycemia begets hypoglycemia [abstract]. Diabetes 2012;61:A58-A59.
6. Garg S, Brazg RL, Bailey TS, Buckingham BA, Klonoff DC, Shin J, Welsh JB, Kaufman FR: Automatic insulin pump suspension for induced hypoglycemia: the ASPIRE study [abstract]. Diabetes 2012;61:A59.
7. Danne T, Kordonouri O, Holder M, Haberland H, Golembowski S, Remus K, Bläsig S, Wadien T, Zierow S, Hartmann R, Thomas A: Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy. Diabetes Technol Ther 2011;13:1129-1134.
8. Choudhary P, Shin J, Wang Y, Evans ML, Hammond PJ, Kerr D, Shaw JA, Pickup JC, Amiel SA: Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk. Diabetes Care 2011;34:2023-2025.
9. Ly TT, Nicholas JA, Retterath A, Davis EA, Jones TW: Analysis of glucose responses to automated insulin suspension with sensor-augmented pump therapy. Diabetes Care 2012;35:1462-1465.
10. Agrawal P, Welsh JB, Kannard B, Askari S, Yang Q, Kaufman FR: Usage and effectiveness of the low glucose suspend feature of the Medtronic Paradigm Veo insulin pump. J Diabetes Sci Technol 2011;5:1137-1141.
11. Bergenstal RM, Klonoff DC, Garg SK, Bode BW, Meredith M, Slover RH, Ahmann AJ, Welsh JB, Lee SW, Kaufman FR; the ASPIRE In-Home Study Group: Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med 2013;369:224-232.
12. Gastaldelli A, Toschi E, Pettiti M, Frascerra S, Quinones-Galvan A, Sironi AM, Natali A, Ferrannini E: Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients. Diabetes 2001;50:1807-1812.
13. König M, Bulik S, Holzhütter HG: Quantifying the contribution of the liver to glucose homeostasis: a detailed kinetic model of human hepatic glucose metabolism. PLoS Comput Biol 2012;8:e1002577.
14. Galassetti P, Mann S, Tate D, Neill RA, Wasserman DH, Davis SN: Effect of morning exercise on counterregulatory responses to subsequent, afternoon exercise. J Appl Physiol 2001;91:91-99.
15. Arbelaez AM, Powers WJ, Videen TO, Price JL, Cryer PE: Attenuation of counterregulatory responses to recurrent hypoglycemia by active thalamic inhibition: a mechanism for hypoglycemia-associated autonomic failure. Diabetes 2008;57:470-475.
16. Cryer PE: Hypoglycemia begets hypoglycemia in IDDM. Diabetes 1993;42:1691-1693.